Alcon Inc. (SWX:ALC)

Market Cap	29.96B -26.7%
Revenue (ttm)	8.12B +4.3%
Net Income	834.86M -9.8%
EPS	1.67 -10.2%
Shares Out	491.20M
PE Ratio	36.43
Forward PE	24.12
Dividend	0.28 (0.46%)
Ex-Dividend Date	May 13, 2025

Volume	196,215
Average Volume	1,091,740
Open	60.94
Previous Close	61.00
Day's Range	60.32 - 60.94
52-Week Range	57.68 - 87.00
Beta	0.69
RSI	44.90
Earnings Date	Feb 25, 2026

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,000
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: ALC

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial numbers in USD